Dipartimento Farmaco Chimico Tecnologico, Università degli Studi di Siena, Siena, Italy.
J Med Chem. 2011 Aug 11;54(15):5444-53. doi: 10.1021/jm200476p. Epub 2011 Jul 6.
Experimental evidence suggests that selective CB2 receptor modulators may provide access to antihyperalgesic agents devoid of psychotropic effects. Taking advantage of previous findings on structure-activity/selectivity relationships for a class of 4-quinolone-3-carboxamides, further structural modifications of the heterocyclic scaffold were explored, leading to the discovery of the 8-methoxy derivative 4a endowed with the highest affinity and selectivity ever reported for a CB2 ligand. The compound, evaluated in vivo in the formalin test, behaved as an inverse agonist by reducing at a dose of 6 mg/kg the second phase of the formalin-induced nocifensive response in mice.
实验证据表明,选择性 CB2 受体调节剂可能提供没有精神作用的抗痛觉过敏药物。利用先前关于一类 4-喹诺酮-3-羧酰胺的结构-活性/选择性关系的发现,进一步探索了杂环支架的结构修饰,导致发现了具有最高亲和力和选择性的 8-甲氧基衍生物 4a,这是迄今为止报道的 CB2 配体。该化合物在福马林试验中进行了体内评估,作为反向激动剂,在 6mg/kg 剂量下可减少小鼠福马林诱导的伤害性反应的第二阶段。